Compare PLSE & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | PGNY |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2015 | 2019 |
| Metric | PLSE | PGNY |
|---|---|---|
| Price | $21.35 | $17.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $22.00 | ★ $27.10 |
| AVG Volume (30 Days) | 323.0K | ★ 1.7M |
| Earning Date | 06-01-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.04 |
| EPS | N/A | ★ 0.65 |
| Revenue | N/A | ★ $1,288,661,000.00 |
| Revenue This Year | $912.86 | $9.57 |
| Revenue Next Year | $259.66 | $10.06 |
| P/E Ratio | ★ N/A | $27.08 |
| Revenue Growth | N/A | ★ 10.40 |
| 52 Week Low | $12.56 | $16.76 |
| 52 Week High | $26.30 | $28.75 |
| Indicator | PLSE | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 59.65 | 31.36 |
| Support Level | $13.75 | $16.76 |
| Resistance Level | $26.30 | $22.71 |
| Average True Range (ATR) | 1.27 | 0.99 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 95.24 | 15.43 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.